Why we should improve current practice of diagnosing and treating pulmonary large cell neuroendocrine carcinomas in patients with advanced disease

Jules Derks, Robert Jan van Suylen, Erik Thunnissen, Michael den Bakker, Harry Groen, Egbert Smit, Ronald Damhuis, Esther van den Broek, Ernst-Jan Speel, Anne-Marie C. Dingemans

Source: Eur Respir J, 50 (4) 1701658; 10.1183/13993003.01658-2017
Journal Issue: October
Disease area: Thoracic oncology

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jules Derks, Robert Jan van Suylen, Erik Thunnissen, Michael den Bakker, Harry Groen, Egbert Smit, Ronald Damhuis, Esther van den Broek, Ernst-Jan Speel, Anne-Marie C. Dingemans. Why we should improve current practice of diagnosing and treating pulmonary large cell neuroendocrine carcinomas in patients with advanced disease. Eur Respir J, 50 (4) 1701658; 10.1183/13993003.01658-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does large airway intervention for patients with malignant disease result in early clinical benefit?
Source: Annual Congress 2008 - Hot and cold techniques
Year: 2008


Does large airway intervention for patients with malignant disease result in early clinical benefit
Source: Eur Respir J 2007; 30: Suppl. 51, 434s
Year: 2007

Can IASLC/ATS/ERS subtype help predict response to chemotherapy in small biopsies of advanced lung adenocarcinoma?
Source: Eur Respir J 2014; 43: 1240-1242
Year: 2014


Challenges in molecular testing in lung cancer patients with advanced disease
Source: International Congress 2016 – Lung cancer: latest developments in screening and patient management
Year: 2016


Coexistence of chronic obstructive pulmonary disease in patients with advanced non-small cell lung cancer and impact on survival
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017


What specific issues arise in the management of elderly patients with advanced NSCLC?
Source: Annual Congress 2007 - Treatment of metastatic nonsmall cell lung cancer in the era of targeted therapies
Year: 2007


Current challenges in diagnosing and treating adults with interstitial lung disease
Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease
Year: 2014




Managing the initial treatment and multiple relapses in a small cell lung cancer patient with limited disease
Source: International Congress 2018 – CC3 Lung cancer: personalised treatment and palliative care
Year: 2018


Pancreatic polypeptide is increased in patients with advanced malignant disease including lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 232s
Year: 2002

Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer (ED SCLC)
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019


Clinically relevant information obtained by endobronchial ultrasonography in the management of early stage squamous cell carcinomas prior to photodynamic therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 6s
Year: 2001

Analysis of lung adenocarcinoma in patients aged 70 and over: The viewpoint of clinical stage, therapeutic modality and prognosis
Source: Eur Respir J 2002; 20: Suppl. 38, 269s
Year: 2002

Is lung ultrasound useful in diagnosing and monitoring children with neuroendocrine cell hyperplasia of infancy?
Source: International Congress 2017 – Rare diseases
Year: 2017


The use of surgical services in the management of suspected lung cancers
Source: Annual Congress 2012 - Epidemiology and care research of lung cancer
Year: 2012


Symptomatic benefit of short regimen of palliative radiotherapy for elderly patients with locally advanced non small cell lung cancer
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010

The management of GERD in patients with advanced lung disease: drugs or surgery?
Source: Annual Congress 2009 - The role of gastro-oesophageal reflux in advanced lung disease
Year: 2009

The clinical value of autoflurescence bronchoscopy for precancerous lesions in operable primary lung cancer patients
Source: Annual Congress 2007 - Diagnostic bronchoscopy and transthoracic aspiration
Year: 2007


The need for early MDT assessment of lung cancer patients presenting with pain
Source: Eur Respir J 2003; 22: Suppl. 45, 432s
Year: 2003

Earlier stages, higher incidence of squamous and lower incidence of small cell and adenocarcinomas among lung cancer patients with coexisting COPD
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009

The benefit of surgical lung biopsy in diagnosis and prognosis of diffuse infiltrative lung disease
Source: Annual Congress 2007 - Staging, diagnostic procedures and complex situations in thoracic surgery
Year: 2007